Spatial differences in active caspase-8 defines its role in T-cell activation versus cell death

Cell Death and Differentiation

Volumn 15, Issue 11, 2008, Pages 1701-1711

  Koenig, A ^a   Russell, J Q ^a   Rodgers, W A ^b   Budd, R C ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CD3 ANTIGEN; DNA; FAS ANTIGEN; PROTEIN BID;

APOPTOSIS; ARTICLE; CELL CYCLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LEUKEMIA CELL LINE; LIPID RAFT; LYMPHOCYTE ACTIVATION; NICK END LABELING; PRIORITY JOURNAL; SUCROSE GRADIENT; T LYMPHOCYTE ACTIVATION; ULTRACENTRIFUGATION;

ANTIGENS, CD3; ANTIGENS, CD95; CASPASE 8; CELL DEATH; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMANS; JURKAT CELLS; KINETICS; LYMPHOCYTE ACTIVATION; MEMBRANE MICRODOMAINS; PROTEIN TRANSPORT; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 54049100321     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.100     Document Type: Article

References (44)

1. Cohen GM. Caspases: The executioners of apoptosis. Biochem J 1997; 326 (Part 1): 1-16.
2. Kumar S. Caspase function in programmed cell death. Cell Death Differ 2007; 14: 32-43.
3. Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: Master switches of inflammation. Cell Death Differ 2007; 14: 10-22.
4. Lamkanfi M, Festjens N, Declercq W, Vanden Berghe T, Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ 2007; 14: 44-55.
5. Donepudi M, Grutter MG. Structure and zymogen activation of caspases. Biophys Chem 2002; 101-102: 145-153.
6. Ho PK, Hawkins CJ. Mammalian initiator apoptotic caspases. The FEBS Journal 2005; 272: 5436-5453.
7. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene 2003; 22: 8543-8567.
8. Salvesen GS. Caspase 8: Igniting the death machine. Structure 1999; 7: R225-R229.
9. Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003; 10: 26-35.
10. Salvesen GS, Dixit VM. Caspase activation: The induced-proximity model. Proc Natl Acad Sci USA 1999; 96: 10964-10967.
11. Chun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002; 419: 395-399.
12. Salmena L, Lemmers B, Hakem A, Matysiak-Zablocki E, Murakami K, Au PY et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883-895.
13. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 1997; 387: 569-572.
14. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1: 31-39.
15. He HT, Lellouch A, Marguet D. Lipid rafts and the initiation of T cell receptor signaling. Semin Immunol 2005; 17: 23-33.
16. Russell S, Oliaro J. Compartmentalization in T-cell signalling: Membrane microdomains and polarity orchestrate signalling and morphology. Immunol Cell Biol 2006; 84: 107-113.
17. Misra RS, Russell JQ, Koenig A, Hinshaw-Makepeace JA, Wen R, Wang D et al. Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappa B adaptors during T cell activation. J Biol Chem 2007; 282: 19365-19374.
18. Edidin M. The state of lipid rafts: From model membranes to cells. Annu Rev Biophys Biomol Struct 2003; 32: 257-283.
19. Lagerholm BC, Weinreb GE, Jacobson K, Thompson NL. Detecting microdomains in intact cell membranes. Annu Rev Phys Chem 2005; 56: 309-336.
20. Rodgers W. Making membranes green: Construction and characterization of GFP-fusion proteins targeted to discrete plasma membrane domains. Biotechniques 2002; 32: 1044-1046, 1048, 1050-1041.
21. Kennedy NJ, Kataoka T, Tschopp J, Budd RC. Caspase activation is required for T cell proliferation. J Exp Med 1999; 190: 1891-1896.
22. Misra RS, Jelley-Gibbs DM, Russell JQ, Huston G, Swain SL, Budd RC. Effector CD4+ T cells generate intermediate caspase activity and cleavage of caspase-8 substrates. J Immunol 2005; 174: 3999-4009.
23. Juo P, Kuo CJ, Reynolds SE, Konz RF, Raingeaud J, Davis RJ et al. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol Cell Biol 1997; 17: 24-35.
24. Juo P, Kuo CJ, Yuan J, Blenis J. Essential requirement for caspase-8/ FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 1998; 8: 1001-1008.
25. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
26. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, Cohen GM. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 1996; 315 (Part 1): 21-24.
27. Janes PW, Ley SC, Magee AI. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J Cell Biol 1999; 147: 447-461.
28. Duplay P, Thome M, Herve F, Acuto O. p56lck interacts via its src homology 2 domain with the ZAP-70 kinase. J Exp Med 1994; 179 1163-1172.
29. Manders M, Verbeek PJ, Aten JA. Measurement of co-localization of objects in dual colour confocal images. J Microsc 1993; 169: 375-382.
30. Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW et al. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem 2002; 277: 45162-45171.
31. Edidin M. Lipids on the frontier: A century of cell-membrane bilayers. Nat Rev Mol Cell Biol 2003; 4: 414-418.
32. Harder T. Lipid raft domains and protein networks in T-cell receptor signal transduction. Curr Opin Immunol 2004; 16: 353-359.
33. Glebov OO, Nichols BJ. Lipid raft proteins have a random distribution during localized activation of the T-cell receptor. Nat Cell Biol 2004; 6: 238-243.
34. Magee T, Pirinen N, Adler J, Pagakis SN, Parmryd I. Lipid rafts: Cell surface platforms for T cell signaling. Biol Res 2002; 35: 127-131.
35. Zacharias DA, Violin JD, Newton AC, Tsien RY. Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 2002; 296: 913-916.
36. Kabouridis PS. Lipid rafts in T cell receptor signalling. Mol Membr Biol 2006; 23: 49-57.
37. Chichili GR, Rodgers W. Clustering of membrane raft proteins by the actin cytoskeleton. J Biol Chem 2007; 282: 36682-36691.
38. Manes S, Viola A. Lipid rafts in lymphocyte activation and migration. Mol Membr Biol 2006; 23: 59-69.
39. Lemmers B, Salmena L, Bidere N, Su H,Matysiak-Zablocki E, Murakami K et al. Essential role for caspase-8 in Toll-like receptors and NF-kappaB signaling. J Biol Chem 2007; 282: 7416-7423.
40. Su H, Bidere N, Zheng L, Cubre A, Sakai K, Dale J et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005; 307: 1465-1468.
41. Egawa T, Albrecht B, Favier B, Sunshine MJ, Mirchandani K, O'Brien W et al. Requirement for CARMA1 in antigen receptor-induced NF-kappa B activation and lymphocyte proliferation. Curr Biol 2003; 13: 1252-1258.
42. Gaide O, Favier B, Legler DF, Bonnet D, Brissoni B, Valitutti S et al CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol 2002; 3: 836-843.
43. Lanzavecchia A, Scheidegger D. The use of hybrid hybridomas to target human cytotoxic T lymphocytes. Eur J Immunol 1987; 17: 105-111.
44. Muppidi JR, Siegel RM. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat Immunol 2004; 5: 182-189.